about
DG-CST (Disease Gene Conserved Sequence Tags), a database of human-mouse conserved elements associated to disease genesIn-vivo real-time control of protein expression from endogenous and synthetic gene networksInferring genetic networks and identifying compound mode of action via expression profilingChemogenomic profiling on a genome-wide scale using reverse-engineered gene networksReverse engineering a mouse embryonic stem cell-specific transcriptional network reveals a new modulator of neuronal differentiationHow to turn a genetic circuit into a synthetic tunable oscillator, or a bistable switchA reverse-engineering approach to dissect post-translational modulators of transcription factor's activity from transcriptional dataComputational framework for the prediction of transcription factor binding sites by multiple data integration.CoGemiR: a comparative genomics microRNA database.A mouse embryonic stem cell bank for inducible overexpression of human chromosome 21 genes.A parallel implementation of the network identification by multiple regression (NIR) algorithm to reverse-engineer regulatory gene networks.Identification of small molecules enhancing autophagic function from drug network analysis.The phytoestrogen genistein modulates lysosomal metabolism and transcription factor EB (TFEB) activationModeling RNA interference in mammalian cellsA community-based resource for automatic exome variant-calling and annotation in Mendelian disorders.Construction and modelling of an inducible positive feedback loop stably integrated in a mammalian cell-lineInference of gene regulatory networks and compound mode of action from time course gene expression profiles.Colocalization of coregulated genes: a steered molecular dynamics study of human chromosome 19.Network based elucidation of drug response: from modulators to targets.A network-based approach to dissect the cilia/centrosome complex interactome.Drug-set enrichment analysis: a novel tool to investigate drug mode of actionBlood transcriptomics of drug-naïve sporadic Parkinson's disease patients.Deficiency of multidrug resistance 2 contributes to cell transformation through oxidative stress.Unravelling druggable signalling networks that control F508del-CFTR proteostasisHigh-resolution analysis of the human retina miRNome reveals isomiR variations and novel microRNAs.Direct targets of the TRP63 transcription factor revealed by a combination of gene expression profiling and reverse engineeringId proteins synchronize stemness and anchorage to the niche of neural stem cells.A genome-scale modeling approach to study inborn errors of liver metabolism: toward an in silico patient.TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop.An atlas of gene expression and gene co-regulation in the human retina.Autophagosome-lysosome fusion triggers a lysosomal response mediated by TLR9 and controlled by OCRLMiRNAs confer phenotypic robustness to gene networks by suppressing biological noise.Systems and Synthetic biology: tackling genetic networks and complex diseases.Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds.Engineering and control of biological systems: A new way to tackle complex diseases.Transcriptional network dynamics in macrophage activation.PML-RARA-associated cooperating mutations belong to a transcriptional network that is deregulated in myeloid leukemias.Reverse engineering transcriptional gene networks.Comparing structural and transcriptional drug networks reveals signatures of drug activity and toxicity in transcriptional responses.Evaluation of a systems biology approach to identify pharmacological correctors of the mutant CFTR chloride channel.
P50
Q24793058-A157CB9D-3069-4431-90BF-F946B33F27DDQ27322499-1F6B0C7C-121B-46E4-936D-6A31E418E72EQ28185053-635373C4-2222-4998-B070-E68D16330876Q28239582-FF899AF0-086D-4E9C-B367-39D4C853D24EQ28592241-8283DFBD-147A-46D8-B363-883F432CB88EQ30974536-106EB993-CDB3-42AB-A237-85FC09E01C9EQ30991256-EAF85458-0CF4-4044-B41A-5D279358C818Q31079282-86EBB01A-BDEA-41CA-BF16-59CE3FE94BB0Q33374149-05061DB1-A375-4037-8924-E184FAC8E21BQ33452667-CDCEDDD4-06B2-47D7-B85A-908728A99861Q33565561-37B9BB6C-AA67-4C31-AFB5-75C2663B9DF1Q33712703-97BD1B47-BDFD-49F0-9974-5F031A0593B5Q33761283-BAE6EFFE-2993-4C05-A637-6BB267FBF278Q33805528-B5484D08-6B00-4CF7-920B-1EC24A6DE327Q33851555-815FC0F9-1C44-4606-9B22-0252FF850809Q33963719-BF56EAB8-3BB6-4626-8AC5-9AC85632B75AQ34485459-14983CDC-8A9F-4FAA-91E1-1E46E05B444FQ34649568-CF4F6F71-AD12-4551-8B6C-B2BDE234E3A2Q35065347-66DF76F0-B23A-4B9B-9B90-52053447403EQ35221299-0837ABD9-DA68-4AB1-AECF-8EA99C7F1333Q35790801-5A78DB3D-BE73-42FD-BF08-23B9025BA3DBQ35824982-7994B929-7D93-4B1F-AA7F-42D4970FCF3BQ36429362-E77BEAC5-74C7-4FA4-9CE1-390DFD343F41Q36568529-2AD15DBF-5146-4357-8D35-A0CE83CEF0DEQ36627980-F68F4884-EED8-47B4-B99B-60C276D1EEBFQ36700199-B101FD63-28B4-4EB4-BAD9-41249587924FQ36792676-EB9F431D-A221-46A0-A432-65F4E69F973FQ36822239-567A9ADC-E44C-420C-ADD6-88A9056F5134Q36977543-05CCC9CF-905E-4EAF-AF7A-34AE49C89CEBQ37076345-AEFB7D7E-33EA-4821-9919-E94CDE0CE48AQ37292836-6BA6134D-3EA2-4D64-81E5-9D2AFAF61110Q37331613-2D59947E-2BBE-46F3-8252-52A8EDC24902Q37405937-3B47A818-AF91-42A9-9D9C-09D8C1EAF4ECQ37644761-D11FB9DE-091C-4022-8936-C97EC8580634Q38009596-F064B199-6175-44C0-B7C7-BFA675C38B16Q38313362-CA9385CA-FC61-440A-8D3F-D06D4A8A68C9Q38438690-D024FE92-8CD2-4AF1-8C0C-EDEBBD98A4DFQ38483411-2D02BBE6-8CEF-4B5D-85BB-C58607C2941BQ38598719-7FCDFAD6-8D7D-423A-8FEB-F4A85F05A000Q38786788-5C6F347C-9E92-4227-AE1A-28B252E7882C
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Diego di Bernardo
@ast
Diego di Bernardo
@en
Diego di Bernardo
@es
Diego di Bernardo
@nl
Diego di Bernardo
@sl
type
label
Diego di Bernardo
@ast
Diego di Bernardo
@en
Diego di Bernardo
@es
Diego di Bernardo
@nl
Diego di Bernardo
@sl
prefLabel
Diego di Bernardo
@ast
Diego di Bernardo
@en
Diego di Bernardo
@es
Diego di Bernardo
@nl
Diego di Bernardo
@sl
P106
P1153
15842797800
8689306500
P21
P31
P496
0000-0002-1911-7407